Clinical Trial Update: Single-dose Prophylactic INdomethacin in Extremely Preterm Infants [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a single-dose prophylactic indomethacin in extremely preterm infants to prevent intraventricular hemorrhage; status is not yet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraventricular Hemorrhage
• Preterm Birth

Drugs mentioned

• INDOMETHACIN (INDOMETHACIN)

Snippet

Sponsor: University of British Columbia | Conditions: Extreme Prematurity, Intraventricular Hemorrhage | Phase 2 | Status: NOT_YET_RECRUITING